Who Owns Armata Pharmaceuticals Stock?
NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 13.65%
- Held by insiders
- 67.64%
- Institutional holders
- 82
- Institutions 13.7%
- Insiders 67.6%
- Public and other 18.7%
Who owns Armata Pharmaceuticals stock?
Institutional investors own about 13.7% of Armata Pharmaceuticals's shares, spread across 82 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 67.64% of ARMP.
The largest institutional holders are Madison Asset Management, LLC (5.67%), Blackrock Inc. (1.51%) and Vanguard Capital Management LLC (1.31%). Together, the top 10 institutions control 12.1% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ARMP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ARMP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Madison Asset Management, LLC | 2.11M | 5.67% | -0.0% |
| Blackrock Inc. | 559.99K | 1.51% | +760.9% |
| Vanguard Capital Management LLC | 487.97K | 1.31% | +33.3% |
| Millennium Management Llc | 470.50K | 1.27% | +82.4% |
| Geode Capital Management, LLC | 278.54K | 0.75% | +3.0% |
| Dauntless Investment Group, LLC | 203.89K | 0.55% | +125.1% |
| State Street Corporation | 129.60K | 0.35% | +155.1% |
| Grey Ledge Advisors LLC | 100.00K | 0.27% | +100.0% |
| Northern Trust Corporation | 89.79K | 0.24% | +264.3% |
| Vanguard Portfolio Management LLC | 81.35K | 0.22% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ARMP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 349.60K | 0.94% |
| iShares Trust-iShares Russell 2000 ETF | 198.08K | 0.53% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 131.12K | 0.35% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 125.87K | 0.34% |
| iShares Trust-iShares Russell 2000 Growth ETF | 112.36K | 0.30% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 67.62K | 0.18% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 56.00K | 0.15% |
| iShares Trust-iShares Micro-Cap ETF | 37.92K | 0.10% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 28.86K | 0.08% |
| Quantitative Master Series LLC-Master Small Cap Index Series | 22.17K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Armata Pharmaceuticals?
Madison Asset Management, LLC is the largest institutional shareholder of ARMP, owning 5.67% of shares outstanding (2.11M shares) as of its latest 13F filing.
What percentage of Armata Pharmaceuticals is owned by institutions?
Institutions own about 13.7% of ARMP shares and 42.2% of the public float.
How much of Armata Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 67.64% of ARMP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.